Susquehanna International Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Susquehanna International Group’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,500	Closed	-$267K	–	13868
2023 Q4	$267K	Sell	23,500 -100	-0.4%	-$786	﹤0.01%	10066
2023 Q3	$95.1K	Buy	+23,600	New	+$175K	﹤0.01%	10964
2022 Q2	–	Sell	-1,380	Closed	-$69K	–	14333
2022 Q1	$69K	Sell	1,380 -2,190	-61%	-$114K	﹤0.01%	12145
2021 Q4	$270K	Sell	3,570 -2,250	-39%	-$154K	﹤0.01%	10736
2021 Q3	$460K	Buy	5,820 +4,140	+246%	+$416K	﹤0.01%	9613
2021 Q2	$233K	Sell	1,680 -550	-25%	-$105K	﹤0.01%	11274
2021 Q1	$467K	Buy	2,230 +840	+60%	+$168K	﹤0.01%	9642
2020 Q4	$231K	Sell	1,390 -720	-34%	-$111K	﹤0.01%	9802
2020 Q3	$358K	Buy	+2,110	New	+$304K	﹤0.01%	8354

Susquehanna International Group's HARP Position: Q2 2023 in Review

Susquehanna International Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 5,395 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in HARP in Q3 2020 and held it in 10 quarters. The position peaked at $1.9M in Q1 2021. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

Susquehanna International Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 5,395 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $40.1K.
Susquehanna International Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Susquehanna International Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2021.
44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.